Advances in cardiac surgery toward the mid-20th century created a need for an artificial means of stimulating the heart muscle. Initially developed as large external devices, technological advances resulted in miniaturization of electronic circuitry and eventually the development of totally implantable devices. These advances continue to date, with the recent introduction of leadless pacemakers. In this first part of a 2-part review, we describe indications, implant-related complications, basic function/programming, common pacemaker-related issues, and remote monitoring, which are relevant to the practicing cardiologist. We provide an overview of magnetic resonance imaging and perioperative management among patients with cardiac pacemakers. (J Am Coll Cardiol 2017;69:189-210) 
AC-powered pacemakers tethered to an extension cord (Furman) 1950s Historically, pacing developed using large, external, alternating current (AC)-powered devices, which subsequently evolved to "wearable" transistorized battery powered pacemakers-both comprise the era of external devices. A paradigm shift occurred with the introduction of the entirely implantable pacemaker, composed of an extravascular pulse generator connected to a transvenous lead in contact with the myocardium. This paradigm continues to this day. An emerging and rapidly developing new paradigm is that of leadless pacemakers, which are available for clinical use. Batteryless pacemakers that harvest cardiac mechanical motion to generate current, or that modify or add cells to introduce biological pacing activity, are under active investigation. rate. An atrioventricular clock is then started. In the absence of an intrinsic ventricular event, a ventricular pacing spike is triggered; a sensed intrinsic ventricular event inhibits pacing. In all pacing modes, a lower rate limit indicates the rate below which pacing occurs (this is the slowest heart rate that should be present, although some features and algorithms may permit programmable exceptions), and an upper rate limit indicates the fastest rate at which the pacemaker will pace, although intrinsic cardiac activity has no such limit. DDD. Standard dual-chamber pacing is used when the sinus mode is intact, but AV conduction impaired.
A B B R E V I A T I O N S
Sinus activity is sensed and will trigger ventricular pacing following a programmed AV delay (p-synchronous pacing). on a tracing from an ambulatory monitor. This is best seen at the fifth ventricular complex. A P-wave precedes the intrinsic ventricular event, but this is not sensed (green arrow), and an atrial pacing artifact (black arrow) occurs immediately before the intrinsic ventricular complex.
The ventricular complex is sensed in the cross-talk sensing window. As a result, the ventricular pacing artifact (red arrow) is delivered early after the intrinsic ventricular event (i.e., ventricular safety pacing).
Mulpuru et al.
Cardiac Pacing: Part 1 atrial lead. In current clinical practice, these modes are only used temporarily to prevent oversensing.
BASIC PROGRAMMABLE FEATURES
Several basic programmable features are important for arrhythmia management. Class IIa: Permanent Pacemaker Implantation Is Reasonable for 1. Sinus node dysfunction with heart rates <40 beats/min when a clear association between significant symptoms consistent with bradycardia and the actual presence of bradycardia has not been documented. 2. Syncope of unexplained origin when clinically significant abnormalities of sinus node function are discovered or provoked in electrophysiological studies.
Class IIb: Permanent Pacemaker Implantation May Be Considered in 1. Minimally symptomatic patients with chronic heart rate <40 beats/min while awake. algorithms can lead to pacing below the programmed lower rate. Pause-dependent cases of ventricular proarrhythmia were reported in patients with RV pacing avoidance algorithms (12) (13) (14) .
In contrast to standard dual-chamber pacemakers, biventricular pacemakers aim to maximize ventricular pacing to deliver the highest possible dose of cardiac resynchronization therapy (CRT, discussed in part 2 [4] Table 1) . Mulpuru et al. Note that several loops on the ventricular lead can put strain on the lead, leading to fracture and high impedance. C o n g e s t i v e h e a r t f a i l u r e . Patients with depressed ventricular function, a wide QRS interval, and symptomatic heart failure benefit from cardiac resynchronization pacing, with reductions in heart failure and mortality, discussed in detail in part 2 (4).
IMPLANT-RELATED COMPLICATIONS
Complication rates range from <1% to 6% with current implant tools and techniques. These are broadly divided into immediate/procedure-related, intermediate-term, and long-term or late complications ( Table 3) . Their prompt recognition permits timely management.
IMMEDIATE PROCEDURE-RELATED COMPLICATIONS.
Transvenous lead placement requires venous puncture in the pre-pectoral region. Due to the proximity of the apex of the lung to vascular targets, pneumothorax ( Figure 7A ) and hemothorax occur in up to 1% of cases. During implantation, the risk is Excess scar at the incision site is associated with unfavorable cosmetic result, pain, and discomfort.
Hypertrophic scar ( Figure 10A ) and keloid formation ( Figure 10B ) are due to excess interstitial tissue (Figures 11 and 12A ). An insulation break results in low impedance and PVC ¼ premature ventricular beat; other abbreviations as in Figure 5 . 
PERIOPERATIVE MANAGEMENT OF PACEMAKERS
Electrosurgery is the application of a 100-kHz to Electrosurgery-related EMI may also cause a poweron reset (abrupt reversion to nominal mode and pacing parameters), pulse generator damage, atrial and ventricular arrhythmia, or tissue injury at the lead-tissue interface, although these are uncommon (33, 34) . The risk of electrosurgical EMI depends on the surgical site and dispersive pad location, with the highest risk for surgery of the heart and chest, followed by the head and neck, shoulder/upper extremity, and abdomen-pelvis. In our experience, pacemaker EMI is nonexistent with hip and lower extremity surgery when the dispersive pad is applied to the lower extremities ( Figures 16A and 16B ). 
CMR OF PATIENTS WITH PACEMAKERS
CMR has become ubiquitous, so that 75% of patients with pacemakers will likely need a scan at some time following implantation (36) . In the 1980s, adverse events, including death, occurred when patients with pacemakers were (usually unknowingly) scanned, as pacemaker leads could act as antennae in the CMR environment, with induced currents during imaging leading to risk of arrhythmia induction, capture threshold changes, and device damage ( Table 4) In several large series, including the Mayo Clinic series that now exceeds 1,000 scans, imaging of patients with legacy pacemakers has been safely performed ( Figure 18) (37,38) . The greatest potential risk is that of power-on reset in pacemakerdependent patients, which may change the programmed mode from asynchronous to synchronous, permitting oversensing of CMR signals and inhibition of pacing output. This was seen in a limited number of older devices from a specific manufacturer (39) .
Nearly all patients with legacy systems can be safely 
